Dr. Ahmad AlSarraf
Consultant Clinical Lipidologist, Sabah Al Ahmad Cardiac Center
Kuwait City, Kuwait
Biography
Ahmad J AlSarraf MD, FRCPC, ABCL
PERSONAL INFORMATION:
Name: Ahmad Al-AlSarraf.
Gender: Male.
Position: Medical Biochemistry & Clinical lipidologist senior specialist, Kuwait Cancer Control Center. Program Director, Clinical Biochemistry and Metabolic Medicine
Date of birth: October 30, 1974
Citizenship: Kuwaiti
Address: Mubarek Al-Jaber. Block 1, street 106 House # 56
E-mail: [email protected] or [email protected]
Phone number: 69032002, 99638437
Previous position:
Kuwait Cancer Control Center Laboratories Director (2014-2018)
Head and member of the Clinical biochemistry committee in Kuwait (2013-2018)
CREDENTIALS:
Doctor of Medicine (MD) – Arabian Gulf University, 1999
Lipid management – University of Southern Indiana, 2007
American Board of Clinical Lipidology, 2010
The Royal College of Physicians and Surgeons of Canada (FRCPC) - Medical Biochemistry May 2011
CURRENT STATUS:
Laboratory director of Dasman Diabetes Institute Clinical Laboratory
Program director, Clinical Biochemistry and Metabolic Medicine
Head unit, Clinical Biochemistry Laboratory - KCCC
PROJECTS:
Familial Hypercholesterolemia registry in Vancouver, BC
The European Atherosclerosis Society (EAS) Familial Hypercholesterolemia Studies Collaboration (FHSC)
The Gulf Familial Hypercholestrolemia Registry (Gulf FH)
Kuwait Familial Hypercholestrolemia Registry Vitamin D Protocol, Kuwait National lipid Screening program (campaign)
1
(EMAN) Eastern Mediterranean Approach for Control of Non Communicable Diseases Survey of Risk Factors for Chronic Non Communicable Diseases (Collaboration with WHO)
Newborn Screening Program
EXPERIENCE:
Laboratory Director of Kuwait Cancer Control Center
Head and Member of the Clinical Biochemistry Committee
Examination Head, Clinical Biochemistry and Metabolic Medicine
AWARD:
2010 HDL Workshop Travel Award for Young Investigations (1000 CAD)
ACADEMIC BACKGROUND:
Medical school: College of Medicine and Medical Sciences, Arabian Gulf University, Bahrain, 1993-1999.
Degrees:
Bachelor in Basic Sciences.
Doctor of Medicine (MD), 29 June 1999.
The Royal College of Physicians and Surgeons of Canada (FRCPC) - Medical Biochemistry May 2011
American Board of Clinical Lipidology, 2010
TEACHING:
Kuwait:
Date: 2004, 2005, 2006, 2012, 2013, 2014, 2015, 2018
Location: School of Medicine, Kuwait University
The Public Authority for Applies Education and Training
Description: Sessions for undergraduate students and medical students.
PUPLICATIONS:
1. Treatment of renal calculi by lithotripsy: minimizing short-term shock wave induced renal damage by using antioxidants. Al-awadi KA, Kehinde EO, Loutfi I, Mojiminiyi OA, Al-hunayan A, Abdul-halim H, Al-sarraf A, Memon A, Abraham MP .Urological research 2008; 36: 51-60
2. An assessment of clinical utility of transperineal urethrosphincteric block (TUSB) in outpatient rigid cystoscopy: a single- blind, randomized study. A. Al-Hunayan, E. O. Kehinde, A. Shihab-Eldeen, H. Abdulhalim and A. Al-Saraf. Int. Urol Nephrol 2009; 41:47-53.
2
3. Bisalbuminuria detected by agarose gel electrophoresis. Al-Sarraf A, Chow C, Garg A. Clin Biochem. 2010; 43:534-6.
4. Hepatic lipase deficiency in a Middle-Eastern/ Arabic male. Al Riyami N, Al-Ali A, Al-Sarraf A, Hill J, Sachs-Barrable K, Hegele R, Wasan K, Frohlich J. BMJ Case Reports 2010; doi:10.1136/bcr.12.2009.2589.
5. Complete Apo AI Deficiency in an Iraqi Mandaean Family: Case studies and review of the literature – Al-Sarraf A, Al-Ghofaili K, Sullivan DR, Wasan KM, Hegele R, Frohlich J. J Clin Lipidol. 2010; 4:420-6.
6. Central pontine myelinolysis following orthotopic liver transplantation – a rare complication Al-Sarraf A, Haque M, Pudek M, Yoshida EM. Exp Clin Transplant. 2010; 8:321-4.
7. Fish odour syndrome. Li M, Al-Sarraf A, Sinclair G, Frohlich J. CAMJ. 2011; 183(8):929-31.
8. Cholesterol efflux capacity and atherosclerosis. Frohlich J, Al-Sarraf A. N Engl J Med. 2011; 364:1474-5.
9. Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: A retrospective cohort study. Supna Sandhu, Ahmad Al-Sarraf, Catalin Taraboanta, Jiri Frohlich, and Gordon A. Francis. Lipids Health Dis. 2011 Sep 11; 10:157.
10. Statin resistant dyslipidemia in a patient treated with amiodarone. Al-Sarraf A, Li M, Frohlich J. BMJ Case Reports 2011; doi:10.1136/bcr.08.2011.4620. (14 Oct 2011).
11. Use of once-weekly statin in combination with ezetimibe in a patient with mitochondrial disease. Li M, Al-Sarraf A, Mattman A, Frohlich J. BMJ Case Reports 2012; doi:10.1136/bcr.12.2011.5369. (24 April 2012)
12. Cardiovascular risk and atherosclerosis prevention. Frohlich J, Al-Sarraf A. Cardiovasc Pathol. 2012 Apr 11 (Available online 11 April 2012).
13. Regional and National Familial Hypercholesterolemia Registries: Present International Application, Importance and Needs for Canada. Al-Sarraf A, Allard M, Martinka M, Frohlich J. In press in CJC (accepted 30 April 2012. published online 21 June 2012)
14. Dr. Fredrickson: Founding Father of the Field of Lipidology. Wong S, Al-Sarraf A, Ignaszewski A, Frohlich J. BCMJ. 2012, 54: 336-40.
15. Safety of statin therapy in patients with mitochondrial diseases (Letter to the Editor). Fady Hannah-Shmouni, Ahmad Al-Sarraf, Jiri Frohlich, Michelle M. Mezei, Sandra Sirrs, Andre Mattman. In press in J Clin Lipidol.
3
16. Paediatric type III dyslipidaemia: a case of vanishing hyperlipidaemia. Sarwal G, Al-Sarraf A, Frohlich J. BMJ Case Reports 2012; doi:10.1136/bcr-2012-007579 (1 November 2012)
17. Low prevalence of type 2 diabetes mellitus among patients with high levels of high-density lipoprotein cholesterol. Andrew J. Juren, Gautamn Sarwal, Ahmad Al-Sarraf, Michal Vrablik, Darren Chan, Karin H. Humphries, Jiri Frohlich. J Clin Lipidol. 2013; 7(3):194-8.
18. Exercise in a healthy heart program: a cohort study. Meikle J, Al-Sarraf A, Li M, Grierson K, Frohlich J. Clin Med Insights Cardiol. 2013;15;7:145-51
19. Familial hypercholesterolemia mutations in the Middle Eastern and North African region: A need for a national registry. Bamimore MA, Zaid A, Banerjee Y, Al-Sarraf A, Abifadel M, Seidah NG, Al-Waili K, Al-Rasadi K, Awan Z. J Clin Lipidol. 2015; 9(2):187-194.
20. The Gulf Familial Hypercholestrolemia Registry (Gulf FH), Design, Rationale and Preliminary Results Al-Rasadi K, Alhabib KF, Al-Allaf F, Al-Waili K, Al-Zakwani I, AlSarraf A, Almahmeed W, AlSayed N, Alghamdi M, Batais MA, Almigbal TH, Alnouri F, Kinsara A, Hammouda A, Awan Z, Kary H, Elamin OA, Zadjali F, Al-Jarallah M, Shehab A, Sabbour H, Amin H, Altaradi H. Curr Vasc Pharmacol. 2018 Oct 5.
21. Overview of the current status of familial hypercholesterolemia care in over 60 countries – The EAS Familial Hypercholesterolemia Studies Collaboration (FHSC). EAS Familial Hypercholesterolemia Studies Collaboration; EAS Familial Hypercholesterolemia Studies Collaboration (FHSC) Investigators. Atherosclerosis. 2018 Oct;277:234-255.
PROJECTS:
Familial Hypercholesterolemia registry in Vancouver, BC
The European Atherosclerosis Society (EAS) Familial Hypercholesterolemia Studies Collaboration (FHSC)
The Gulf Familial Hypercholestrolemia Registry (Gulf FH)
Kuwait Familial Hypercholestrolemia Registry Vitamin D Protocol, Kuwait National lipid Screening program (Campaign)
(EMAN) Eastern Mediterranean Approach for Control of Non Communicable Diseases Survey of Risk Factors for Chronic Non Communicable Diseases (Collaboration with WHO)
EXAM:
Lipid management – University of Southern Indiana, 2007
American Board of Clinical Lipidology, 2010
The Royal College of Physicians and Surgeons of Canada (FRCPC) - Medical Biochemistry May 2011
4
MEMBERS:
Royal College of Physician and Surgeons of Canada
American Association for Clinical Chemistry, AACC
National Lipid Association, NLA
Canadian Journal of Cardiology, CJC European Atherosclerosis Society (EAS)
EAS FH Studies Collaboration (FHSC) International Atherosclerosis Society, IAS
CONFERENCES:
1. ‘New Trends in the Management of Lymphoma’: International symposium, (November 6-8, 2000)
2. Symposium on Update of Thyroid Diseases (Oct. 28-30, 2002).
3. XII Congress of the Pan Arab Association of Surgeons Symposium: Interdisciplinary neurosurgical aspects (Dec. 13-16, 2002).
4. First Annual Kuwait Postgraduate Assembly in Surgery (Dec. 14-17, 2002).
5. Workshop on Percutaneous Tracheostomy (Dec. 22nd, 2002).
6. Kuwait Plast 2004 (April 11-14, 2004):
a. 5th International Congress of Kuwait Society of Plastic Surgery.
b. 1st Kuwait Congress of Bariatric Surgery.
c. 2nd Middle East Congress for Head & Neck Aesthetic & Reconstructive Surgery.
7. The First Arab Congress for Laparoscopic Surgery (Nov. 27-29, 2004).
8. Second Kuwait-German Urological Symposium: Updates on Renal Oncology (Feb. 19th, 2005).
9. Faculty seminar: An Endocrine Basis for the Low Incidence of Prostate Cancer in Arabs (Feb. 28th, 2005).
10. Non-Surgical Treatment of BPH (Mar. 1st, 2005).
11. 17th Saudi Urology Conference (Mar 8-10, 2005)
12. I spent a period of time as an observer at Mansoura Hospital, Egypt - Urology department (April 23-28, 2005).
13. 1st update in Urologic Laparoscopy (May 14-15,2005)
14. 3rd Kuwait Urological Association Meeting (Update on Urolithiasis) (Feb 11-12, 2006), I was the coordinator of the meeting.
15. 18th Saudi Urology Conference (20-23 Feb, 2005). I presented a video clip of a retroperitoneal radical laparoscopic nephrectomy.
16. AACC annual meeting (July 2008)
17. Professional Practice in clinical chemistry: A review and update (April 19-23, 2009)
18. Canadian Association of Medical Biochemists (Oct. 7-9, 2009). I presented a poster of CETP in Rare dyslipidemias
19. The 6th International IAS-sponsored Workshop on High Density Lipoproteins. (May 17-19 2010). I presented a poster of Characterization of patients with very high plasma HDL-cholesterol, with and without vascular pathology. Travel Award for Young Investigations
20. Masters in Lipidology course Feb, 2010
21. Physician Management Institute – Foundation Level Negotiation and conflict management (June 21-23, 2010)
22. AACC annual meeting ( July 2010)
5
23. 2011 Annual Scientific Sessions, Personalizing Prevention: Lipids and Atherosclerosis Risk sponsored by the National Lipid Association and hosted by the Northeast regional chapter. (May 19-22, 2011)
24. CIQC/CAP-ACP-Diagnostic Immunohistochemistry and Molecular Pathology (June 2 -3, 2011)
25. Canadian Laboratory Medicine Congress (June 4-8, 2011) A Joint Congress of the Canadian Association of Pathologists (CAP-ACP) and the Canadian Society of Clinical Chemists (CSCC-SCCC).
26. Physician Management Institute – Foundation Level self-awareness and effective leadership (June 21-23, 2011)
27. Statistical Methods for Clinical Laboratories Certificate Program. AACC online certificate programs - July 2011.
28. 2012 Deuel Conference on Lipids (March 6 – 9, 2012)
29. NLA Clinical Lipid Update (March 9–11, 2012)
30. USCAP- The Society for Cardiovascular Pathology. March 2012
31. Diabetes Update in Pediatric and Adult Age Groups. (November 11-12, 2012)
32. The 2nd Kuwait International Conference on Head and Neck Cancer. (April 3-6, 2013)
33. Update in Common Endocrine Disorders. (May 5-6, 2013)
34. Workshop on Mass Spectrometry in the Clinical Laboratory. (October 27-29, 2013) I was the coordinator of the meeting
35. Bone Disorders Secondary to Endocrine Disorders & Diabetes. (January 12-13, 2014). Presented Vitamin D protocol and guidelines.
36. Quality Matters in the Laboratory: Assuring Patient Safety, Optimizing Efficiency and Releasing Trapped Cash. (January 26, 2014) I was the coordinator of the meeting.
37. 2014 Deuel Conference on Lipids: Obesity, Diabetes and atherosclerosis (March 4– 7, 2014)
38. The European Heart House (March 20-21, 2014)
39. 2014 Roche EMEA Tumor Marker Workshop (September 4-5, 2014)
40. KCCC/UHN Pathology (November 1-3, 2014) Conference chair
41. IAS-OSLA Course on “Lipid Metabolism and Cardiovascular Risk” (February 8-10, 2015). Presented Lipid Management in special populations
42. The 3rd Kuwait International Conference on Head and Neck Cancer (April 8-11, 2015)
43. Recent advances in Endocrine Disorders (April 26-27, 2015). Presented Vitamin D deficiency management.
44. The International Association of Forensic Toxicologists (TIAFT 2015) (August 30 – September 4, 2015)
45. Kuwaiti Society for Endocrinology (October 18-19, 2015) presented lipid disorders
46. KCCC/UHN Pathology (November 8-10, 2015) Conference chair
47. National lipid association (March 19-20, 2016)
48. AACC American Association of Clinical Chemistry (August 1-5, 2016)
49. KCCC/UHN 3rd annual pathology conference and 1st Clinical biochemistry board review (November 1-3, 2016) Conference chair
50. European Atherosclerosis Society (EAS) (April 21-26, 2017)
51. AACC annual meeting (July 30 – August 3, 2017)
52. Point of care testing advances conference (September 30, 2017)
53. Kuwait institute for medical specialization (October 4, 2017)
54. 3rd annual meeting Saudi society for Clinical Chemistry (November 20-23, 2017) presented chemistry calculation and equations
55. 4th annual pathology conference and 2nd Clinical biochemistry board review (November 4-6, 2017) Conference chair
56. Kuwait Medical Laboratory and Public Health Conference (March 20-22, 2018)
6
57. Diabetes and Endocrine Disorders for Health Professionals (April 8-9, 2018) presented management of lipid disorder in pediatrics population
58. Genitourinary and Gynecological Cancer Kuwait Conference (April 14-16, 2018)
59. Update on clinical laboratory sciences 2018 Meeting (April 17-18, 2018)
60. International Conference on Breast and pelvic malignancies (April 26-28, 2108)
61. International forum on Quality and Safety in Healthcare 2018 (May 2-4, 2018) presented poster A journey to improve patients experience in the Fine Needle Aspiration Clinic
62. 86th EAS Congress (May 5-8, 2018)
63. Wales External Quality Assurance Scheme (November 27-28, 2018)
64. Egyptian Association of Vascular Biology and Atherosclerosis (November 20-23, 2018) presented Non-fasting lipid profile
65. Kuwait Society of Endocrinology (November 25-26, 2018) presented Pathophysiology of lipid disorders